Programme
Monday, September 21, 2026
-
08:00–09:15
Morning Abstract and Concurrent Sessions
-
08:00–09:00
Local/Regional insights for global organ donation advancement
Chairs: Gabriel E. Gondolesi (US); Chloë Ballesté Delpierre (ES)
- 08:00–09:00 Personalizing immunosuppression in liver transplantation: From microbiome to malignancy
-
08:00–09:00
Vasculopathy: A tale of three organs
What should we continue to learn from renal allograft pathologyMariam Alexander (US)
-
08:00–08:45
Takeda Corporate Breakfast Symposium on Illuminated constellations: How diverse experiences guide practical CMV
Organized by
-
09:15–10:30
Plenary and Concurrent Sessions
-
09:15–10:30
Plenary Session 2 on Making Xenotransplantation Work for Humanity!
Chairs: Peter Cowan (AU); Macey L. Levan (US)
Clinical xenotransplantation: Experience to dateTatsuo Kawai (US)Xenozoonosis, no worries!Anoma Nellore (US)Let’s start with hearts (or lungs?)!Richard N. Pierson (US)Let’s start with islets!Wayne J. Hawthorne (AU)The ethics of new technology in xenotransplantationLuz Padilla (US)Panel DiscussionDiscussion Period (AU) -
09:15–10:30
Beyond survival: Addressing mental health in transplantation
Why survival alone is not sufficient for transplant successsMariel Nöhre (DE)Psychological distress across the transplant journeyIris Fontanilla (NZ)Practical strategies for integrating mental health in transplant careMing Hwei Yek (US)Panel DiscussionDiscussion Period (AU)
-
09:15–10:30
Dedicated donor care units: Centralized donor transfer and outcome optimization
Chairs: David Thomson (ZA); Dan Harvey (GB)
25 years of innovation: The St. Louis donor care unitGary F. Marklin (US)The US donor care unit landscapeJennifer Prinz (US)Panel DiscussionDiscussion Period (AU) -
10:30–11:00
Coffee Break / Exhibits and Poster Viewing
-
10:30–11:00
Coffee Break
-
11:00–12:00
Abstract and Concurrent Sessions
-
11:00–12:00
DCD: Controlled and uncontrolled—Where are we going?
Chair: Kenneth J. Woodside (US)
Role of ICU physiciansSara Alcantara Carmona (ES)Question PeriodDiscussion Period (AU) -
11:00–12:00
The -omic era in allograft pathology
Does metabolic phenotype in the kidney affect transplant outcome?Ana Konvalinka (CA)Endogenous peptides in T cell allorecognition and beyond – Lessons from preclinical modelsAlexandra Sharland (AU)
-
11:00–12:00
Transplantation journals: Updates and opportunities
Chairs: Stefan Tullius (US); Fadi Issa (GB)
Structure, achievements, goals – Getting your work published, recognized and highlightedStefan Tullius (US)Transplant-Direct: The online campaign journal with an own agendaEdward Geissler (DE)AI and publishing: When, how and what is legit?Germaine Wong (AU) -
12:00–13:30
Lunch Break / Industry Symposia / Lunch with Experts & Mentors
-
12:15–13:15
Hansa BioPharma Corporate Lunch Symposium on Transplanting the untransplantable – Idefirix® (imlifidase), a breakthrough innovation for highly sensitised kidney transplantation
Organized by
-
12:30–13:15
Lunch and Learn Roundtable
CMV GuidelineAtul Humar (CA)Medical Assist in Dying (MAID) and benefit to organ donationMatthew Weiss (CA)Survival outcome impact related to distance from transplant centerSusumu Eguchi (JP)Pediatric cardiovascular health and patient survivalAnette Melk (DE)Induction and mechanisms of transplant toleranceXunrong Luo (US)Alternative islet transplant sitesToby Coates (AU)Transplant policy, development and education to improve access and quality of kidney transplantation across Latin AmericaPaola Karina Garcia Padilla (CO)Roundtable MentorGabriel E. Gondolesi (US)Roundtable MentorHelen Opdam (AU)Roundtable MentorDorry Segev (US)Roundtable MentorSiah Kim (AU)Roundtable MentorFadi Issa (GB)Immunological monitoring of the pancreas graftPablo Uva (AR)
-
13:30–15:00
SOTA, Thematic and Concurrent Sessions
-
13:30–15:00
Innovating the Pathway: Allied Health Contributions to Advancing Organ Donation and Transplantation
Chair: Anne Floden (SE)
Driving excellence in transplant care: The role, vision and impact of the tts allied health committeeEstephan Arredondo (ES)Extending organ viability: The role of allied health in machine perfusion programsJoaquim Albiol (ES)Strategies to improve adherence after solid organ transplantationMariel Nöhre (DE)Panel discussionBronwyn Levvey (AU)Panel DiscussionDiscussion Period (AU) -
13:30–15:00
Bridging Transplantation and Regenerative Medicine: Enhancing Graft Viability and Exploring Stem Cell-Islet Immunotherapies in Diabetes
Chair: Ahmer Mohammad Hameed (AU)
Pancreas transplantation in type 2 diabetes mellitusPeter G. Stock (US)Diagnosis and treatment of pancreas rejectionPablo Uva (AR)Islets and stem cells in diabetes therapy: Current statusEelco de Koning (NL) -
13:30–15:00
Minimal Invasive Transplantation
Minimally invasive thoracic organ transplantationAlbert Jauregui (ES)Minimally invasive abdominal organ transplantationKwang Woong Lee (KR)Education and training strategies to safely disseminate robotic organ transplantationJinna Yao (AU)Future technological development in robotic organ transplantationDieter Broering (SA)
-
13:30–15:00
Donor Evaluation and Optimization: Bridging Safety and Organ Utilization
mNGS and rapid diagnostics: The next frontier in donor screening?Maricar Malinis (US)HIV-positive organ donation: Evolving guidelines and global perspectivesCameron Wolfe (US)MDRO: Cross-disciplinary approaches to donor-derived infection risk assessmentPriscilla Rupali (IN)Donors in the tropics and LMICs: What to consider?Siriorn Watcharananan (TH)
-
13:30–15:00
Using Technology to optimize outcomes of Liver Transplantation
Chair: Shantanu Bhattacharya (AU)
Ischemia-free organ transplantationGuo Zhiyong (CN)The future for artificial Intelligence in liver transplantDorry Segev (US) -
13:30–15:00
Precision Immune Engineering in Kidney Transplantation
Next-generation co-stimulation blockadeCheng Yang (CN)Regulatory T-cell therapy 2.0: CAR-TregsMegan Levings (CA)Emerging pharmacotherapies for desensitization in HLA incompatible kidney transplantationMarta Crespo Barrio (ES)
-
13:30–15:00
Advancing Uterus Transplantation: Global Practices, Innovations, and Program Development
Global uterus transplantation activities and outcomes: the ISUTx registryMats Brännström (SE)Robotic surgery in uterus transplantationJean-Marc Ayoubi (FR)Setting up a uterus transplantation programRebecca Deans (AU)Updates on treatment and donor/recipient selectionPaige Porrett (US)
-
13:30–15:00
Harnessing the Power of Genetics in Pediatric Transplantation
Overview of genomic sequencing techniquesKatherine E. Twombley (US)When and why to consider genetic testing pre-transplantHugh McCarthy (AU)Bioethics in transplant gene testingAnne Priesz (AU)
-
13:30–15:00
How to combat transplant tourism
Chair: Thomas F. Müller (CH)
Patients traveling overseas for transplants - Practical experiencesAnantharaman Vathsala (SG)Challenges in registering unethical travel for transplant activitiesDominique Martin (AU)The living donor liver registryDimitri A. Raptis (SA)Tools to detect and report suspicious cases of traffickingMaria Amalia Matamoros (CR)Panel DiscussionDiscussion Period (AU) -
13:30–15:00
Senotherapy in transplantation
Global and local consequences of ‘environmental sciences’ on organ ageStefan Tullius (US)Cell-type and sex specific aspects of senescenceAnette Melk (DE)Aged immune systems drives organ agingMatthew Yousefzadeh (US)
-
13:30–15:00
Bridging Systems, Scaling Access: Asia-Pacific Leadership in Transplantation
Equity and access in fragile health systems: A south asian perspectiveDivya Singh Shah (NP)
-
13:30–15:00
The mentorship mosaic: Fostering growth in transplant training and practice
Chairs: Sarah Tsou (US); Natasha Rogers (AU)
Panel discussantFriederike Martin (DE)Panel discussantGomathy Narasimhan (IN)Panel discussantKhushboo Saxena (IN) -
13:30–15:00
Building high-performing transplant registries: Global consensus recommendations and a practical maturity framework
Chair: Sang Joseph Kim (CA)
Opening remarks and overview: From fragmented data to global alignment. Why transplant registries need a shared frameworkSang Joseph Kim (CA)Creating a transplant registry: Defining purpose, scope, and sustainable infrastructureGermaine Wong (AU)Establishing trust: Governance, ethics, and legal architecture of transplant registriesAxel Rahmel (DE)From aspirational standards to practical assessment: Introducing the transplant registry maturity modelYee Lu (US)Panel DiscussionDiscussion Period (AU)PanelistNicole Jane Scholes-Robertson (AU) -
15:00–15:30
Coffee Break / Exhibits and Poster Viewing
-
15:00–15:30
Coffee Break
-
15:30–16:30
Afternoon Abstract and Concurrent Sessions
-
15:30–17:00
From patient to planet: The global essential standards as a framework for transformative change in transplantation
Chair: John J. Fung (US)
The human face of standardsJohn J. Fung (US)Dignity for all: The human covenant: How the global essential standards protect every individual in the transplant encounterEfstratios (Stratos) Chatzixiros (CH)The institutional blueprint: How the global essential standards create a transplant ecosystem that is equitable, safe, and self-sustainingMedhat Askar (QA)Stakeholders perspective from China: Translating standards into value for every actor in the ecosystemHaibo Wang (CN)Stakeholders perspective from Australia: Translating standards into value for every actor in the ecosystemHelen Opdam (AU)Connecting the circles: Panel discussionsDiscussion Period (AU)PanelistKaren Rockwell (GB) -
15:30–16:30
Advancing ABO histocompatibility: Needs and solutions
ABO antigens and antibodies: Updating old dogmasAnne Halpin (CA)ABO incompatible kidney transplantation, strategies and successesMarta Crespo Barrio (ES)
-
15:30–16:30
Expanding donor access: The impact of ECMO in thoracic transplantation a TTS/ISHLT Conjunct Session
Chairs: Pablo Sanchez (US); Raj Ramanan (US)
The role of NRP and machine perfusion in cardiothoracic transplantationSandra Lindstedt Ingemansson (SE)Complex decisions: Ethical dilemmas of ECMO, DCD and NRP donorsEmily Granger (AU) -
16:45–18:00
Workshop Sessions / Industry Symposium / Poster Sessions
-
16:45–18:00
Sex, cancer, and the graft: What women need most from transplant care
Do women do better or worse – What the data say across cancer and transplant?Brenda Maria Rosales (AU)Post transplant care: Patient perspectivesNicole Jane Scholes-Robertson (AU)
-
16:45–18:00
Transplant without borders: Collaborative solutions for global kidney care
The global interdependence of health and the burden of kidney disease as a pressing public health priorityBenita Padilla (PH)Transplant knowledge and skills transfer: the role of collaborative partnerships in reducing disparities in kidney disease-related morbidity and mortalityShyam Bihari Bansal (IN)Overcoming the challenges in achieving equity in global access to kidney transplantationBeatriz Domínguez-Gil (ES)
-
16:45–18:00
Optimizing cardiometabolic health across the lifespan following transplantation
-
16:45–18:00
Poster Session 1
-
17:00–18:00
Industry Symposium
-
18:00–20:00
Networking Events
-
18:00–19:00
WIT Networking Event
-
19:00–21:00
Early Career Networking